NCT02145130View on ClinicalTrials.gov

Phase I Study for Autologous Dermal Substitutes and Dermo-epidermal Skin Substitutes for Treatment of Skin Defects

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions
Burn InjurySoft Tissue InjurySkin NecrosisScarsCongenital Giant NevusSkin Tumors
Interventions
BIOLOGICAL

denovoDerm

Transplantation of an autologous tissue-engineered dermal substitute, covered with autologous split-thickness skin

BIOLOGICAL

denovoSkin

Transplantation of autologous tissue-engineered dermo-epidermal skin substitute, no additional coverage needed

Trial Locations (2)

8032

University Children's Hospital Zurich: denovoDerm, Zurich

University Children's Hospital Zurich: denovoSkin, Zurich

All Listed Sponsors
collaborator

University Hospital, Zürich

OTHER

lead

University of Zurich

OTHER

NCT02145130 - Phase I Study for Autologous Dermal Substitutes and Dermo-epidermal Skin Substitutes for Treatment of Skin Defects | Biotech Hunter | Biotech Hunter